Samsung Pharm (001360) — Free Cash Flow Generation Index

Latest as of June 2022: 0.60x

Samsung Pharm (001360) has a Free Cash Flow Generation Index of 0.60x as of June 2022. Free cash flow of ₩952.48 Million represents 1% of operating cash flow (₩1.59 Billion). Explore how much does Samsung Pharm reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.60x

Free Cash Flow / Operating CF

Free Cash Flow

₩952.48 Million

KRW

Operating Cash Flow

₩1.59 Billion

KRW

Capital Expenditures

₩638.30 Million

KRW

Samsung Pharm Free Cash Flow Generation Index (2017–2017)

Historical FCF Generation Index trend for Samsung Pharm across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Samsung Pharm generate cash.

Annual Free Cash Flow Generation for Samsung Pharm (2017–2017)

Year-by-year Free Cash Flow Generation Index for Samsung Pharm. Check Samsung Pharm (001360) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (KRW)	Operating CF	Capital Expenditures	YoY Change
2017	-0.16x	₩-847.92 Million	₩5.15 Billion	₩6.11 Billion	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).